BRANFORD, Conn., Sept. 25, 2014 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will be participating in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium, to be held September 29 and 30 in New York City.
On Tuesday, September 30, Mr. Patton will participate on two panels, including the Non-Invasive Monitoring Can Save Lives panel, to be held from 11:00 a.m. to 11:25 a.m., and the Laboratory vs. Hospital Launch panel, being held from 2:55 p.m. to 3:20 p.m.
The BTIG Symposium features leading diagnostics companies participating in a series of thematic panels to familiarize attendees with the diagnostics sector and associated technologies and to foster an understanding of how the tools work and why they should be adopted.
About CASMED® – Monitoring What's Vital
CASMED is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation. Direct monitoring of tissue oxygenation provides a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues, thereby allowing them to intervene appropriately in the care of their patients. In addition to FORE-SIGHT Oximeters and accessories, the Company provides a line of bedside patient vital signs monitoring products, proprietary non-invasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies, and service. CASMED products are designed to provide unique monitoring solutions that are vital to patient care. For more information regarding CASMED, visit the Company's website at www.casmed.com.
CAS Medical Systems, Inc.
Jeffery A. Baird
Chief Financial Officer
Source:CAS Medical Systems, Inc.